PRNP and prion disease: Further studies are necessary to determine whether these PrPC-binding Nbs could complement the currently most promising therapies against prion disease, specifically the reduction of PrPC expression through antisense oligonucleotides [33], genome editing using targeted epigenetic approaches [34], or base editing strategies [35].